Immunitybio Inc is trading 4.1% down at $6.99 today, primarily driven by a broad market selloff and general risk-off sentiment.
- The stock's decline appears to be macro-driven, as major indices trade sharply lower and risk assets face significant pressure.
- There is no fresh company-specific news flow, regulatory updates, or major analyst calls tied to today's price action.
- While underperforming recent sessions, the move remains broadly aligned with the current weak market backdrop rather than a new firm-specific catalyst.